PharmaCorp Rx Inc.
PCRX.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.61M | 7.01M | 9.00M | 8.96M | 19.75M |
| Total Receivables | 564.20K | 471.60K | 259.10K | 227.10K | 164.90K |
| Inventory | 1.77M | 1.24M | 1.13M | 912.60K | 243.80K |
| Prepaid Expenses | 135.10K | 41.40K | 22.40K | 33.40K | 47.70K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 6.08M | 8.77M | 10.41M | 10.13M | 20.20M |
|
|
|||||
| Total Current Assets | 6.08M | 8.77M | 10.41M | 10.13M | 20.20M |
| Net Property, Plant & Equipment | 3.04M | 2.90M | 2.78M | 2.80M | 673.30K |
| Long-term Investments | 10.07M | 9.18M | 7.98M | 7.98M | 1.43M |
| Goodwill | 10.07M | 9.18M | 7.98M | 7.98M | 1.43M |
| Total Other Intangibles | 5.71M | 3.55M | 3.48M | 3.57M | 1.44M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 1.53M | -- | -- | -- |
| Total Assets | 28.51M | 25.93M | 24.66M | 24.47M | 23.75M |
|
|
|||||
| Total Accounts Payable | 2.04M | 1.44M | 1.00M | 1.07M | 364.30K |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 354.10K | 111.20K | 104.70K | 103.80K | 109.80K |
| Total Finance Division Other Current Liabilities | 7.90K | 15.20K | 106.10K | 7.30K | -- |
| Total Other Current Liabilities | 7.90K | 15.20K | 106.10K | 7.30K | -- |
| Total Current Liabilities | 2.40M | 1.57M | 1.21M | 1.18M | 474.10K |
|
|
|||||
| Total Current Liabilities | 2.40M | 1.57M | 1.21M | 1.18M | 474.10K |
| Long-Term Debt | 2.26M | 205.70K | 208.30K | 221.20K | 249.50K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 488.10K | 327.60K | 324.40K | 337.40K | 373.40K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.67M | 1.52M | 1.47M | 1.49M | 390.70K |
| Total Liabilities | 6.82M | 3.62M | 3.21M | 3.23M | 1.49M |
|
|
|||||
| Common Stock & APIC | 23.39M | 23.73M | 22.52M | 22.50M | 24.13M |
| Retained Earnings | -1.86M | -1.59M | -1.24M | -1.41M | -2.06M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 21.52M | 22.14M | 21.28M | 21.09M | 22.07M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 21.52M | 22.14M | 21.28M | 21.09M | 22.07M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 167.50K | 171.00K | 163.40K | 154.60K | 186.90K |
| Total Equity | 21.69M | 22.32M | 21.44M | 21.24M | 22.26M |
|
|
|||||